|
|
|
|
Tharimmune Inc (NASDAQ: THAR) |
|
Price: $1.1500
$-0.02 
-2.086%
|
| Day's High:
| $1.22
| Week Perf:
| 9.52 %
|
| Day's Low: |
$ 1.10 |
30 Day Perf: |
-18.06 % |
| Volume (M): |
11 |
52 Wk High: |
$ 6.45 |
| Volume (M$): |
$ 13 |
52 Wk Avg: |
$2.80 |
| Open: |
$1.18 |
52 Wk Low: |
$0.95 |
|
|
| Market Capitalization (Millions $) |
1 |
| Shares
Outstanding (Millions) |
1 |
| Employees |
- |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-12 |
| Cash Flow (TTM) (Millions $) |
-5 |
| Capital Exp. (TTM) (Millions $) |
0 |
Tharimmune Inc
Company Address: 1200 Route 22 East Bridgewater 8807 NJ
Company Phone Number: 270-8260 Stock Exchange / Ticker: NASDAQ THAR
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
| Stocks on the Move
Published Fri, Jul 26 2024 7:25 PM UTC
Tharimmune Inc. Strengthens Scientific and Strategic Leadership Amidst Financial ResilienceIn a concerted effort to enhance its scientific and strategic direction, Tharimmune, Inc. has made significant appointments and announcements in July 2024, positioning the clinical-stage biotechnology company at the forefront of therapeutic development in inflammation and immunology. ...
|
| Per Share |
Current |
| Earnings (TTM) |
-8.77 $ |
| Revenues (TTM) |
-
|
| Cash Flow (TTM) |
- |
| Cash |
2.75 $
|
| Book Value |
1.01 $
|
| Dividend (TTM) |
0 $ |
|
|
| Per Share |
|
| Earnings (TTM) |
-8.77 $
|
| Revenues (TTM) |
- |
| Cash Flow (TTM) |
- |
| Cash |
2.75 $
|
| Book Value |
1.01 $ |
| Dividend (TTM) |
0 $ |
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
8.57%